Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
The copper moiety may potentially also act as a cofactor for enzymes such as lysyl oxidase and superoxide dismutase
It was originally developed by Metabolic Pharmaceuticals in Australia during the late 1990s as a potential **anti-obesity peptide** that could stimulate fat loss without the growth-promoting or diabetogenic effects of full-length growth hormone
Biochim Biophys Acta (2014) 1845(2):12635
A reasonable titration schedule might look like this: Week 1: 200mcg once daily Week 2: 300mcg once daily Week 3 onward: 300-500mcg based on response and tolerance Optimizing injection technique Poor injection technique contributes to injection site reactions and potentially to other effects like nausea from anxiety around the process
In fact the ELF concentration of GSH is 140 times that of blood serum concentrations
